Predicta Biosciences is a biotechnology company focused on developing innovative diagnostic solutions for personalized medicine. The company specializes in advanced molecular diagnostics, particularly in the areas of cancer detection and monitoring. By leveraging proprietary technologies, Predicta Biosciences aims to improve patient outcomes through early detection and tailored treatment strategies. Their products are designed to provide accurate and reliable results, supporting healthcare professionals in making informed clinical decisions.